%0 Journal Article %T GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells %J - %D 2018 %R 10.1126/scitranslmed.aau7746 %X GPRC5D is an attractive target for immunotherapy of myeloma, and optimized GPRC5D-targeted CAR T cells eradicate myeloma xenografts %U http://stm.sciencemag.org/content/11/485/eaau7746